MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
about
Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer.Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer.Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.Identification and characterization of microRNAs in the intestinal tissues of sheep (Ovis aries).Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer.
P2860
MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA expression profiles a ...... to EGFR, KRAS, and ALK status
@en
MicroRNA expression profiles a ...... to EGFR, KRAS, and ALK status.
@nl
type
label
MicroRNA expression profiles a ...... to EGFR, KRAS, and ALK status
@en
MicroRNA expression profiles a ...... to EGFR, KRAS, and ALK status.
@nl
prefLabel
MicroRNA expression profiles a ...... to EGFR, KRAS, and ALK status
@en
MicroRNA expression profiles a ...... to EGFR, KRAS, and ALK status.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA expression profiles a ...... to EGFR, KRAS, and ALK status
@en
P2093
Choon Taek Lee
Hyojin Kim
Jeong Mi Yang
Jin Ho Paik
Jin-Haeng Chung
Kwhanmien Kim
Sanghoon Jheon
P2860
P304
P356
10.18632/ONCOTARGET.14298
P407
P577
2016-12-27T00:00:00Z